|
Hot Pursuit
23-Feb-24
|
|
|
|
|
|
|
Gland Pharma Ltd slips for fifth straight session
|
Gland Pharma Ltd is quoting at Rs 1871.65, down 1.42% on the day as on 13:19 IST on the NSE. The stock jumped 42.97% in last one year as compared to a 27.42% rally in NIFTY and a 59.26% spurt in the Nifty Pharma index.
|
|
|
Gland Pharma Ltd dropped for a fifth straight session today. The stock is quoting at Rs 1871.65, down 1.42% on the day as on 13:19 IST on the NSE. The benchmark NIFTY is up around 0.17% on the day, quoting at 22254.2. The Sensex is at 73260.38, up 0.14%.Gland Pharma Ltd has lost around 3.37% in last one month.Meanwhile, Nifty Pharma index of which Gland Pharma Ltd is a constituent, has increased around 7.55% in last one month and is currently quoting at 18969.45, up 0.72% on the day. The volume in the stock stood at 2.91 lakh shares today, compared to the daily average of 3.11 lakh shares in last one month. The PE of the stock is 37.42 based on TTM earnings ending December 23.
|
|
Previous News |
Benchmarks trade with significant gains; VIX tumbles 9.39%
(
Market Commentary
-
Mid-Session
07-Aug-24
12:36
)
|
|
Stock alert: Gland Pharma, Gujarat Fluorochem, Ujjivan SFB, Prestige Estates, IREDA
(
Market Commentary
-
Stock Alert
24-Jun-24
08:41
)
|
|
Gland Pharma Ltd slips for fifth straight session
(
Hot Pursuit
-
23-Feb-24
13:35
)
|
|
Gland Pharma slides after Q1 PAT slumps 26% YoY to Rs 144 cr
(
Hot Pursuit
-
07-Aug-24
11:27
)
|
|
Gland Pharma Ltd soars 1.68%, up for fifth straight session
(
Hot Pursuit
-
19-Jun-23
13:00
)
|
|
Gland Pharma to announce Quarterly Result
(
Corporate News
-
29-Dec-21
09:53
)
|
|
Gland Pharma Ltd spurts 4.72%, gains for third straight session
(
Hot Pursuit
-
07-Nov-23
13:05
)
|
|
Gland Pharma
(
Results
-
Analysis
15-Feb-24
11:08
)
|
|
Gland Pharma consolidated net profit declines 25.94% in the June 2024 quarter
(
Results
-
Announcements
06-Aug-24
17:16
)
|
|
Gland Pharma Ltd leads losers in 'A' group
(
Hot Pursuit
-
19-May-23
15:00
)
|
|
Gland Pharma consolidated net profit rises 144.56% in the March 2024 quarter
(
Results
-
Announcements
23-May-24
07:36
)
|
|
|
|
Other Stories |
|
|
|
|
|
|
|
|